What investors are missing about the economy

Key Concepts

• Market Resilience: The ability of the stock market to maintain upward momentum despite geopolitical tensions and macroeconomic headwinds.
• Earnings-Driven Growth: The shift from multiple expansion to earnings-based performance as the primary driver of stock returns.
• CapEx Boom: Massive capital expenditure spending acting as a fiscal stimulus for the economy.
• Transdermal Delivery: A method of administering supplements through the skin, bypassing the digestive tract.
• Optimus (Tesla): A humanoid robot project currently being evaluated by analysts as a "free" upside potential for Tesla investors.

---

1. Market Performance and Sector Analysis

The trading day was characterized by muted, sideways action, yet major indices achieved notable milestones:

• Indices: The Nasdaq Composite and S&P 500 reached record closing highs. The Dow Jones Industrial Average rose 0.2%. Conversely, the equal-weighted S&P 500 finished slightly lower, highlighting the concentration of gains in mega-cap stocks.
• Sector Leaders: Energy (+2.5%) and Technology (+1.3%) led the market.
• Sector Laggards: Communication Services fell 1.2%, largely due to a 3% decline in Alphabet.
• Chip Trade: The Philadelphia Semiconductor Index (SOX) rose 2.5%. Notable performers included Lumentum (+16%), Qualcomm (+8%), and Western Digital (+7%).
• Software Weakness: Shopify (-7%), DocuSign (-5%), and Workday (-5%) saw significant declines.

2. Macroeconomic Outlook and Investment Strategy

Rob Williams (Sage Advisory) provided insights into why the market remains resilient:

• Resilience Factors: The economy is supported by a productivity boom, significant CapEx spending, and solid corporate earnings (averaging 25% growth).
• The "Earnings Carry": Similar to bond yields, investors are seeing returns driven by earnings growth rather than needing multiple expansion (P/E ratio growth).
• Consumer Health: While sentiment is negative due to inflation and gas prices, "hard data" suggests the consumer remains cushioned. High-end consumers are more sensitive to equity market corrections, while lower-end consumers are more sensitive to immediate price shocks like gas.
• Fed Policy: Williams argues the Fed is on hold. Hiking rates is ineffective against supply-side inflation, and cutting rates is unnecessary given the current economic strength.
• Portfolio Positioning: Sage Advisory is maintaining high beta but has shifted toward "growth-oriented value"—companies with earnings momentum that are not limited to the top five mega-cap tech stocks. They are also favoring industrials and infrastructure to capture the CapEx boom.

3. Tesla and the "Optimus" Valuation

Pras Subramanian discussed Piper Sandler’s analysis of Tesla:

• The Thesis: Analyst Alexander Potter suggests that at current share prices (approx. $430–$445), the core automotive business justifies the valuation, effectively making the "Optimus" robot business a "free" option for investors.
• Commercialization: Tesla is moving toward industrializing the production process at the Fremont facility. Musk has indicated that Optimus could be useful outside of Tesla by next year, with the "Gen 3" version expected in July or August.
• Strategic Shift: Piper Sandler notes that while auto demand and regulatory credits are softening, future growth is expected to be driven by Full Self-Driving (FSD) subscriptions and robotaxi deployments.

4. Innovation in Wellness: Barrier

Cleo Davis-Ulmer, CEO of Barrier, introduced the concept of transdermal vitamin patches:

• Methodology: Patches deliver ingredients directly into the bloodstream, bypassing the digestive tract. This addresses issues with pill absorption (e.g., for those with gastric surgeries or leaky gut).
• Adherence: Davis-Ulmer noted that while 98% of people start a supplement routine, less than 40% maintain it. Patches improve adherence through convenience ("stick and forget").
• Product Examples: The company offers daily essentials (Vitamin D, B12), longevity support (NAD), and a specialized "Dear Dairy" patch that releases lactase enzymes over 8–12 hours.
• Business Model: Barrier partners with Walmart (1,700 locations) to ensure accessibility. The products are manufactured in an MHRA-registered facility in the UK.

Synthesis/Conclusion

The market is currently in a phase where strong corporate earnings and a massive capital expenditure cycle are offsetting geopolitical risks and inflationary pressures. Investors are broadening their exposure beyond mega-cap growth into value-oriented sectors with earnings momentum. Simultaneously, the market is increasingly pricing in "moonshot" technologies—such as Tesla’s robotics—as potential future value drivers, while consumer-facing startups like Barrier are leveraging convenience and transdermal technology to disrupt traditional health routines. The overarching theme is a focus on tangible productivity and efficiency, both in the broader economy and in consumer product adoption.